VERONA PHARMA Trademark

Trademark Overview


On Thursday, February 27, 2025, a trademark application was filed for VERONA PHARMA with the United States Patent and Trademark Office. The USPTO has given the VERONA PHARMA trademark a serial number of 99060189. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, August 21, 2025. This trademark is owned by Verona Pharma PLC. The VERONA PHARMA trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of cardiovascular, central nervous system, pulmonary, respiratory, autoimmune diseases and disorders for human use; Pharmaceutical preparations and substances for the treatment of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma

Medical treatment services for the treatment of cardiovascular, central nervous system, pulmonary, respiratory, autoimmune diseases and disorders; Provision of medical information and services; Information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; Medical treatment services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma; Provision of medical information and services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma

Scientific research for medical purposes in the field of the treatment of cardiovascular, central nervous system, pulmonary, respiratory, autoimmune diseases and disorders; Scientific research for medical purposes, namely, the research and development of pharmaceutical preparations for the treatment of respiratory conditions and disease, in particular, chronic obstructive pulmonary disease, cystic fibrosis and asthma
verona pharma

General Information


Serial Number99060189
Word MarkVERONA PHARMA
Filing DateThursday, February 27, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, August 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 9, 2025

Trademark Statements


Description of MarkThe mark consists of the wording "VERONA PHARMA" in stylized font, with a design of a circle with straight lines in varying lengths emanating out from it, and with three of the straight lines in the upper right of the design detached from the circle.
Goods and ServicesPharmaceutical preparations and substances for the treatment of cardiovascular, central nervous system, pulmonary, respiratory, autoimmune diseases and disorders for human use; Pharmaceutical preparations and substances for the treatment of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma
Goods and ServicesMedical treatment services for the treatment of cardiovascular, central nervous system, pulmonary, respiratory, autoimmune diseases and disorders; Provision of medical information and services; Information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; Medical treatment services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma; Provision of medical information and services in the field of respiratory conditions and disease, namely, chronic obstructive pulmonary disease, cystic fibrosis and asthma
NOT AVAILABLE"PHARMA"
Goods and ServicesScientific research for medical purposes in the field of the treatment of cardiovascular, central nervous system, pulmonary, respiratory, autoimmune diseases and disorders; Scientific research for medical purposes, namely, the research and development of pharmaceutical preparations for the treatment of respiratory conditions and disease, in particular, chronic obstructive pulmonary disease, cystic fibrosis and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 28, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 28, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVerona Pharma PLC
Party Type10 - Original Applicant
Legal Entity Type84 - NOT AVAILABLE
AddressCardiff CF10 1FS
GB

Trademark Events


Event DateEvent Description
Thursday, February 27, 2025NEW APPLICATION ENTERED
Tuesday, March 4, 2025TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, February 27, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, March 4, 2025TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Tuesday, March 4, 2025TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, August 2, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 22, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, July 22, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 1, 2025ASSIGNED TO EXAMINER
Saturday, August 2, 2025NON-FINAL ACTION WRITTEN
Saturday, August 2, 2025NON-FINAL ACTION E-MAILED
Thursday, August 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 7, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 11, 2025APPROVED FOR PUB - PRINCIPAL REGISTER